Vivus's Diet Pill Has Heart Benefits That May Support Approval, Study Says

The Food and Drug Administration declined to approve Qnexa in October in part because of concerns that the medicine may cause heart risks and birth defects. Regulators have said they want to see additional benefits of diet pills outside of weight loss …
See all stories on this topic »